PragmaClin Research Inc. is a Canadian startup in the healthcare industry, founded in 2020. Their mission, encapsulated in the slogan "The Future of Care...Starts at Home!", involves the transformation of neurological disease monitoring. The company utilizes innovative digital tools to manage movement disorder assessments from the comfort of patients' homes. Their most recent investment, a $100.00K grant, was secured on 19 September 2023 from the Ontario Brain Institute. This investment signifies the recognition and support PragmaClin has gained from prominent entities in the medical and research field. The company's focus on advancing the accessibility and effectiveness of neurological disease monitoring through home-based assessments makes it a potentially disruptive force in the healthcare sector. The successful acquisition of the grant from the Ontario Brain Institute not only provides crucial financial support but also serves as a testament to the company's potential in addressing fundamental healthcare challenges. As the landscape of healthcare continues to evolve, PragmaClin's innovative approach to disease monitoring positions it as a compelling prospect for investors seeking impactful opportunities in the healthcare technology space.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | $100.00K | 1 | Ontario Brain Institute | 19 Sep 2023 |
Non Equity Assistance | Unknown | 1 | 18 Sep 2023 | |
Grant | $20.00K | 3 | Business Development Bank of Canada | 22 Aug 2023 |
Seed Round | $50.00K | 1 | 27 Apr 2023 | |
Angel Round | $20.00K | 2 | Claudette McGowan, Carol Leaman | 08 Mar 2023 |
No recent news or press coverage available for PragmaClin Research Inc..